P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents
Title:
P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents
Author:
Ntanasis-Stathopoulos, Ioannis Karalis, Vangelis Gavriatopoulou, Maria Sklirou, Aimilia D Malandrakis, Panagiotis Migkou, Magdalini Roussou, Maria Fotiou, Despina Alexopoulos, Harry Eleutherakis-Papaiakovou, Evangelos Theodorakakou, Foteini Kastritis, Efstathios Trougakos, Ioannis P Dimopoulos, Meletios A. Terpos, Evangelos